CAD 0.13
(13.64%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 63.15 Million USD | -14.82% |
2022 | 74.13 Million USD | -22.85% |
2021 | 96.09 Million USD | 0.91% |
2020 | 95.22 Million USD | 0.67% |
2019 | 94.59 Million USD | 36.1% |
2018 | 69.5 Million USD | 73.72% |
2017 | 40 Million USD | 171.6% |
2016 | 14.73 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 12.28 Million USD | 1.36% |
2024 Q1 | 12.12 Million USD | -23.48% |
2023 Q2 | 16 Million USD | -5.9% |
2023 FY | 63.15 Million USD | -14.82% |
2023 Q4 | 15.84 Million USD | 10.85% |
2023 Q3 | 14.29 Million USD | -10.7% |
2023 Q1 | 17.01 Million USD | -9.85% |
2022 Q1 | 19.35 Million USD | -22.04% |
2022 FY | 74.13 Million USD | -22.85% |
2022 Q4 | 18.86 Million USD | 10.75% |
2022 Q3 | 17.03 Million USD | -9.75% |
2022 Q2 | 18.87 Million USD | -2.47% |
2021 FY | 96.09 Million USD | 0.91% |
2021 Q1 | 23.4 Million USD | -13.07% |
2021 Q4 | 24.82 Million USD | 4.75% |
2021 Q3 | 23.7 Million USD | -1.85% |
2021 Q2 | 24.15 Million USD | 3.18% |
2020 Q2 | 21.68 Million USD | 1.01% |
2020 Q1 | 21.46 Million USD | -5.98% |
2020 Q4 | 26.92 Million USD | 7.04% |
2020 FY | 95.22 Million USD | 0.67% |
2020 Q3 | 25.15 Million USD | 16.03% |
2019 Q2 | 25.02 Million USD | 15.3% |
2019 Q1 | 21.7 Million USD | 1.14% |
2019 FY | 94.59 Million USD | 36.1% |
2019 Q4 | 22.82 Million USD | -8.85% |
2019 Q3 | 25.04 Million USD | 0.1% |
2018 Q2 | 17.21 Million USD | 31.51% |
2018 Q1 | 13.09 Million USD | 4.29% |
2018 Q3 | 17.73 Million USD | 3.01% |
2018 FY | 69.5 Million USD | 73.72% |
2018 Q4 | 21.45 Million USD | 20.97% |
2017 Q2 | 9.05 Million USD | 27.23% |
2017 FY | 40 Million USD | 171.6% |
2017 Q1 | 7.12 Million USD | 0.0% |
2017 Q4 | 12.55 Million USD | 11.34% |
2017 Q3 | 11.27 Million USD | 24.45% |
2016 FY | 14.73 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aurora Cannabis Inc. | 270.28 Million CAD | 76.634% |
Avicanna Inc. | 16.79 Million CAD | -276.113% |
Avant Brands Inc. | 26.34 Million CAD | -139.732% |
Cardiol Therapeutics Inc. | - CAD | -Infinity% |
Crescita Therapeutics Inc. | 17.52 Million CAD | -260.433% |
Knight Therapeutics Inc. | 328.19 Million CAD | 80.757% |
MediPharm Labs Corp. | 33.06 Million CAD | -91.02% |
OrganiGram Holdings Inc. | 149.2 Million CAD | 57.672% |
Canopy Growth Corporation | 297.14 Million CAD | 78.746% |
Willow Biosciences Inc. | 1.17 Million CAD | -5288.652% |
Auxly Cannabis Group Inc. | 101.07 Million CAD | 37.519% |